Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01609556
Brief Title: First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Mirvetuximab Soravtansine in Adults With Ovarian Cancer and Other Folate Receptor 1 (FOLR1)-Positive Solid Tumors (IMGN853-0401)

First Submitted : May 30, 2012
First Submitted that Met QC Criteria : May 31, 2012
First Posted : June 1, 2012 (Estimate)

Results First Submitted : February 1, 2019
Results First Submitted that Met QC Criteria : January 27, 2021
Results First Posted : February 17, 2021

Last Update Submitted that Met QC Criteria : January 27, 2021
Last Update Posted : February 17, 2021